Your browser doesn't support javascript.
loading
Source and Purity of Dengue-Viral Preparations Impact Requirement for Enhancing Antibody to Induce Elevated IL-1ß Secretion: A Primary Human Monocyte Model.
Callaway, Justin B; Smith, Scott A; Widman, Douglas G; McKinnon, Karen P; Scholle, Frank; Sempowski, Gregory D; Dittmer, Dirk P; Crowe, James E; de Silva, Aravinda M; Ting, Jenny P-Y.
Afiliação
  • Callaway JB; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America; The Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
  • Smith SA; The Vanderbilt Vaccine Center, Vanderbilt Medical Center, Nashville, TN, United States of America; Department of Medicine, Vanderbilt Medical Center, Nashville, TN, United States of America.
  • Widman DG; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
  • McKinnon KP; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America; The Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
  • Scholle F; Department of Biological Sciences, North Carolina State University, Raleigh, NC, United States of America.
  • Sempowski GD; Duke Human Vaccine Institute, Durham, NC, United States of America.
  • Dittmer DP; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America; The Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
  • Crowe JE; The Vanderbilt Vaccine Center, Vanderbilt Medical Center, Nashville, TN, United States of America; Department of Pathology, Microbiology and Immunology, Vanderbilt Medical Center, Nashville, TN, United States of America; Department of Pediatrics, Vanderbilt Medical Center, Nashville, TN, United Stat
  • de Silva AM; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
  • Ting JP; Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America; The Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America; Department of Genetics, The U
PLoS One ; 10(8): e0136708, 2015.
Article em En | MEDLINE | ID: mdl-26301593

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dengue Grave / Vírus da Dengue / Interleucina-1beta / Anticorpos Antivirais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dengue Grave / Vírus da Dengue / Interleucina-1beta / Anticorpos Antivirais Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos